Fig. 5
The difference in the absorbed compounds in vitro and in vivo. (a The difference in the absorbed compounds in vitro and in vivo of Group A; b The difference in the absorbed alkaloids in vitro and in vivo of Group B.) (Columns: A, l-pyroglutamic acid; B, Fuziline; C, Talatisamine; D, Benzoylmesaconine; E, Benzoylaconine; F, Benzoylhypaconine; G, Mesaconitine; H, Hypaconitine; I, 14-Acetyltalatizamine; J, Chasmanine; K, Neoline; L, Liquiritigenin; M, Liquiritin or Isoliquiritin; N, Isoliquiritigenin; O, Formononetin; P, Glycyrrhizic acid; Q, Glycyrrhetinic acid; R, 6-gingerdione; S, 6-gingerol; T, 6-shogaol; U, Atractylenolide II; V, Atractylenolide I; W, 7-hydroxycoumarin)